Shoichet is the new director of the QB3 at UCSF

Computational chemist Brian Shoichet, PhD, a faculty member in the Department of Pharmaceutical Chemistry, UCSF School of Pharmacy, is the new director of the California Institute for Quantitative Biosciences (QB3) at UCSF.

QB3, with research facilities at UC campuses in San Francisco, Berkeley, and Santa Cruz, has an academic director at each site, as well as a director who oversees operations as a whole.

As director of QB3-UCSF, Shoichet will control a $1.5 million annual budget that supports core research staff and facilities in Byers Hall and Genentech Hall on the UCSF Mission Bay campus. He will also serve on the QB3 Executive Committee.

“What I’m most excited by is that I buy into Brian’s vision of systems pharmacology,” says Regis Kelly, PhD, director of QB3 overall. “He brings together people working in a range of fields, from pharmacokinetics to protein-protein interactions, to see if we can overcome major problems facing the pharmaceutical industry.”

The institute aligns scientists and facilities for research in the quantitative biosciences, which uses the tools of physics, chemistry, and computer science to address biological questions.

The institute also seeks to bring new treatments, tools, and solutions to market via collaboration with industry and support for start-ups via incubator lab facilities. The latter effort includes mentoring, legal, and financial connections for bio-entrepreneurs.

Shoichet follows Andrej Sali, PhD, as QB3’s director at UCSF. Sali, who is a faculty member in Department of Bioengineering and Therapeutic Sciences, a joint department of the UCSF Schools of Pharmacy and Medicine, led the campus program since 2009.


[Brian Shoichet Appointed New Director Of QB3-UCSF; Andrej Sali Steps Down ][link defunct]


School of Pharmacy, Department of Bioengineering and Therapeutic Sciences, Department of Clinical Pharmacy, PharmD Degree Program, BMI, QBC, CCB, Bioinformatics, Biophysics

About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.